Worldwide, there are more than 20 million new cases of cancer each year.
First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal is to unlock the road to precision medicine by using multiomics, spatial data and AI.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Paris, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://rosetta-omics.com/
- Keywords
- oncology, diagnostics, pharmaceutical, liver cancer, biotechnology, companion test, translational research, proteomics, mass spectrometry, medical device, AI, machine learning, digestive cancers, prognosis.
- HQ
- Paris
Rosetta Omics Questions
Rosetta Omics's website is https://rosetta-omics.com/
Rosetta Omics's LinkedIn profile is https://fr.linkedin.com/company/rosetta-proteomics
Rosetta Omics has
10 employees.
View email and phone details for 10
employees at Rosetta Omics.
Rosetta Omics's industry is
Biotechnology Research
Rosetta Omics's top competitors are
Pharmaxyom,
Pharma Recrutement,
Agoranov,
Bacta,
Whitelab Genomics,
Circum Medtech Pharma - A Circum Life Sciences Company,
Omicschart,
Persea,
Altevax Biotech,
Okomera.
Rosetta Omics's categories are Biotechnology Research
Rosetta Omics's founding year is 2022
